Search for: "PFIZER INC. v. TEVA PHARMACEUTICALS USA "
Results 21 - 40
of 70
Sort by Relevance
|
Sort by Date
5 Apr 2012, 11:54 am
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734, at *3 (S.D. [read post]
26 Mar 2012, 1:43 am
Circuit’s 2010 decision in Teva Pharmaceuticals USA, Inc. v. [read post]
2 Mar 2012, 6:52 am
Pfizer (femoral stem) Deposition1998-09-18 In re AMS Minnesota Penile Prosthesis Litigation Deposition1998-12-22 Ethicon, Inc. v. [read post]
24 Jan 2012, 6:34 pm
Akorn’s ANDA, which FDA has not yet tentatively approved, contains a Paragraph IV certification to the ‘269 patent; however, according to the court, non-party Teva Pharmaceuticals USA, Inc. [read post]
20 Oct 2011, 7:18 am
Teva Pharmaceuticals USA, Inc., et. al., 2-10-cv-00128 (VAED October 17, 2011, Order) (Smith, J.) [read post]
18 Jul 2011, 5:16 pm
Circuit’s March 2, 2010 decision in Teva Pharmaceuticals USA, Inc. v. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
2 Jun 2011, 12:46 pm
Pfizer, Inc., 153 S.W.3d 758, 761 (Ky. 2004) (dictum also extends rule to medical devices). [read post]
21 Apr 2011, 1:36 pm
Teva Pharmaceuticals USA, Inc., 2007 WL 5787186 (S.D. [read post]
6 Apr 2011, 12:18 am
195/09 Synthon BV v Merz Pharma GmbH & Co KG (The SPC Blog) Amrix (Cyclobenzaprine) – US: Eurand files patent infringement complaint against Anchen in response to Para IV certification (Patent Docs) Asacol (Mesalamine) – US: NJ District Court punts in Asacol DJ action to trigger 180-day exclusivity forfeiture; Rules that subsequent ANDA applicant lacks standing: Medeva Pharma Suisse v Par Pharmaceuticals (FDA Law Blog) Cialis (Tadalafil) – Israel:… [read post]
8 Nov 2010, 7:35 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
3 Nov 2010, 5:10 am
Teva Pharmaceuticals USA, Inc., 518 F.3d 1353 (Fed. [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says… [read post]
28 Jul 2010, 2:32 pm
Teva Pharmaceuticals USA, Inc., 518 F.3d 1353, 1363 (Fed. [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc. [read post]
23 Jun 2010, 10:28 pm
Teva Pharmaceuticals USA, Inc. et al. [read post]
5 May 2010, 4:46 am
Taro Pharmaceutical USA Inc. et al (Patent Docs) Viagra (Sildenafil) – Brazil patents to expire 1 year early? [read post]
31 Mar 2010, 1:58 pm
Teva Pharm., USA, Inc., 429 F.3d 1364, 1377 (Fed. [read post]
24 Mar 2010, 4:45 am
Teva Pharamceuticals USA, Inc. [read post]
